Ideaya Biosciences Inc
Ideaya Biosciences Inc (IDYA) Straddle
IDYA straddle scan found 42 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 65.2%.
Read more
Trading a IDYA straddle lets you take a pure volatility position on Ideaya Biosciences Inc without committing to a direction. Ideaya Biosciences Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate IDYA straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on IDYA profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Ideaya Biosciences Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the IDYA straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the IDYA straddle is the cleanest expression of that view. Our scanner prices every IDYA straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a IDYA straddle into a catalyst or short a IDYA straddle to harvest decay, the options straddle setups that matter are all in one place.
| Dec 17, 2027 | 45.00 | $18.00 | 409 | 39% | 65.2% | $63.00 | $27.00 | 0 |
| Dec 17, 2027 | 42.50 | $16.78 | 409 | 39% | 64.2% | $59.28 | $25.73 | 1 |
| Dec 17, 2027 | 47.50 | $20.25 | 409 | 39% | 64.0% | $67.75 | $27.25 | 0 |
| Dec 17, 2027 | 40.00 | $16.00 | 409 | 39% | 62.1% | $56.00 | $24.00 | 1 |
| Dec 17, 2027 | 37.50 | $14.75 | 409 | 39% | 61.4% | $52.25 | $22.75 | 0 |
| Apr 16, 2027 | 35.00 | $9.10 | 164 | 39% | 59.9% | $44.10 | $25.90 | 0 |
| Dec 17, 2027 | 35.00 | $14.05 | 409 | 39% | 59.2% | $49.05 | $20.95 | 0 |
| Apr 16, 2027 | 37.50 | $10.70 | 164 | 39% | 58.2% | $48.20 | $26.80 | 1 |
| Apr 16, 2027 | 40.00 | $12.35 | 164 | 39% | 57.4% | $52.35 | $27.65 | 1 |
| Dec 17, 2027 | 32.50 | $13.50 | 409 | 39% | 56.6% | $46.00 | $19.00 | 0 |
As of Nov 5, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →